Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Priya Kishnani is a Pediatrics expert in Durham, North Carolina. Kishnani has been practicing medicine for over 35 years and is rated as an Elite expert by MediFind in the treatment of Gaucher Disease Type 3. She is also highly rated in 12 other conditions, according to our data. Her top areas of expertise are Pompe Disease, Gaucher Disease, Glycogen Storage Disease Type 9, and Glycogen Storage Disease Type 3. She is licensed to treat patients in North Carolina. Kishnani is currently accepting new patients.
Pramod Mistry is a Gastroenterologist in New Haven, Connecticut. Mistry has been practicing medicine for over 39 years and is rated as an Elite expert by MediFind in the treatment of Gaucher Disease Type 3. He is also highly rated in 17 other conditions, according to our data. His top areas of expertise are Gaucher Disease Type 1, Gaucher Disease, Gaucher Disease Type 3, Gaucher Disease Type 2, and Liver Transplant. He is licensed to treat patients in Connecticut. Mistry is currently accepting new patients.
Ari Zimran practices in Jerusalem, Israel. Zimran is rated as an Elite expert by MediFind in the treatment of Gaucher Disease Type 3. He is also highly rated in 16 other conditions, according to our data. His top areas of expertise are Gaucher Disease, Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3, and Hip Replacement.
Summary: The study aims to investigate the transcriptomic and metabolomic changes in blood, plasma and isolated monocytes from Gaucher patients and healthy controls.
Summary: The purpose of this post-marketing survey study is to determine the safety and evaluate effectiveness in participants receiving VPRIV when used in the post-marketing setting and to collect and record genetic mutation data from participants with Gaucher disease.